Publisher
Springer International Publishing
Reference5 articles.
1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.
2. Sin DD, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005;60(12):992–7. https://doi.org/10.1136/thx.2005.045385.
3. Alsaeedi A, Sin DD, Mcalister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med. 2002;113(1):59–65. https://doi.org/10.1016/s0002-9343(02)01143-9.
4. Gold reports for personal use—Global Initiative for Chronic Obstructive Lung Disease. (2019). https://goldcopd.org/gold-reports/. Available 10 Nov 2019.
5. Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, et al. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet. 2016;388(10048):963–73. https://doi.org/10.1016/s0140-6736(16)31354-X.